HUTCHMED (China) Limited - ADR
NASDAQ:HCM
| Market Cap (Intraday) | 2.88B |
| Current PE | 28.44 |
| Forward PE | N/A |
| 2yr Forward PE | 206.25 |
| 10-Day MA | $16.91 |
| 50-Day MA | $16.02 |
| 200-Day MA | $16.02 |
HUTCHMED (China) Limited - ADR Stock, NASDAQ:HCM
Cheung Kong Center, 2 Queen's Road Central, Hong Kong, Central & Western
Hong Kong
Phone: +852.2121.8200
Number of Employees: 1988
Description
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.